Only the 5-mg dose of dapagliflozin, not recommended for cardiovascular risk reduction, showed a reduced benefit. Individual SGLT2 inhibitors showed roughly comparable cardiovascular effectiveness ...
Image Credit: Pixel-Shot/Shutterstock.com A recent BMJ study conducted a randomized trial to evaluate whether a combined therapy of dapagliflozin and calorie restriction had better effectiveness ...
For this study, researchers focused on the SGLT-2 drug dapagliflozin, and how it worked in combination with a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit ...
Diabetes remission was achieved in 44 and 28% of patients in the dapagliflozin and placebo groups, respectively. HealthDay News — For patients with overweight or obesity and type 2 diabetes ...
Combining dapagliflozin with calorie restriction achieved a greater type 2 diabetes (T2D) remission rate and significant changes in body fat and metabolic risk factors than calorie restriction alone.
In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...
After excluding patients with a range of pre-existing conditions, a history of gastric surgery, and those taking weight loss drugs, participants were randomly assigned to either moderate calorie ...
The addition of dapagliflozin alongside moderate calorie restricted diet leads to much higher rates of remission than the diet alone in patients with early type 2 diabetes, a study has concluded. Use ...
Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results